Screener
AdaptHealth AHCO Balance Sheet Statement
| Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | ||
|---|---|---|---|---|---|---|
| $390.39M-0.8% | $391.97M-6.3% | $370.9M-9.1% | $380.32M-5.2% | $393.59M-9.9% | ||
| $105.48M-29.1% | $159.27M+23.2% | $114.89M-17.8% | $149.09M+11.7% | $148.85M+20.1% | ||
| $797.48M+21.2% | $687.48M-7.7% | $728.9M-3.6% | $724.82M+6.0% | $658M-4.1% | ||
| $656.37M+34.5% | $622.19M+29.2% | $503.19M+6.0% | $488.42M+2.8% | $487.99M-1.6% | ||
| $2.37B-10.6% | $2.57B-2.6% | $2.46B-8.1% | $2.65B-2.0% | $2.65B-2.2% | ||
| $31.78M-66.6% | $80.23M-20.0% | $35.77M-66.1% | $90.09M-20.6% | $95.17M-20.0% | ||
| $4.34B-0.2% | $4.42B-0.3% | $4.32B-3.8% | $4.38B-1.9% | $4.35B-3.5% | ||
| $64.74M+15.0% | $59.73M+28.6% | $59.34M+69.8% | $59.85M+67.0% | $56.29M+55.3% | ||
| $8.13M-50.0% | $24.38M+50.0% | $20.31M+25.0% | $16.25M0.0% | $16.25M-59.4% | ||
| $709.21M+14.0% | $743.29M+28.9% | $712.39M+25.6% | $670.7M+21.3% | $622.09M+4.4% | ||
| $1.88B+4.9% | $1.8B-7.3% | $1.72B-12.7% | $1.74B-13.4% | $1.79B-12.1% | ||
| $2.95B+7.2% | $2.91B+1.6% | $2.79B-4.1% | $2.76B-6.4% | $2.76B-8.7% | ||
| $14K+7.7% | $14K+7.7% | $13K0.0% | $13K0.0% | $13K0.0% | ||
| -$782.94M-41.1% | -$649.01M-14.0% | -$632.97M-12.6% | -$530.2M+13.4% | -$554.71M+12.7% | ||
| $1.38B-13.2% | $1.51B-3.9% | $1.52B-3.3% | $1.62B+6.6% | $1.59B+6.8% | ||
| $4.34B-0.2% | $4.42B-0.3% | $4.32B-3.8% | $4.38B-1.9% | $4.35B-3.5% |
FAQ
- What are AdaptHealth's total assets?
- AdaptHealth (AHCO) holds $4.3B in total assets, down 0.2% year over year.
- How much debt does AdaptHealth have?
- AdaptHealth carries $2.1B in total debt against $1.4B of shareholders' equity, a debt-to-equity ratio of 1.50.
- Can AdaptHealth cover its short-term obligations?
- Its current ratio is 1.12 — current assets exceed current liabilities.
- Where does AdaptHealth's balance sheet data come from?
- Every line is extracted from AdaptHealth's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
